NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,725,662 Value ($000) $60,536 Avg Close $36.39 Range $28.19 - $42.00
Q3 2025
Shares 880,552 Value ($000) $25,043 Avg Close $23.97 Range $17.97 - $28.91
Q2 2025
Shares 949,980 Value ($000) $17,204 Avg Close $18.24 Range $14.06 - $22.25
Q1 2025
Shares 619,563 Value ($000) $12,682 Avg Close $22.23 Range $17.18 - $26.80
Q4 2024
Shares 654,710 Value ($000) $16,826 Avg Close $21.24 Range $15.51 - $27.29
Q3 2024
Shares 34,073 Value ($000) $566 Avg Close $17.30 Range $15.19 - $21.48
Q2 2024
Shares 25,387 Value ($000) $488 Avg Close $20.06 Range $16.62 - $24.79
Q1 2024
Shares 1,283,455 Value ($000) $30,354 Avg Close $20.30 Range $11.18 - $26.35
Q4 2023
Shares 1,384,321 Value ($000) $15,463 Avg Close $9.16 Range $5.63 - $11.89